Anti-Olig2 antibody [EPR2673] - Oligodendrocyte Marker and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0435441-V3
- Awardee
- Epitomics Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $856.35
About this award
The University of Virginia awarded contract A207_PO-0435441-V3 to Epitomics Inc on September 26, 2026, for the supply of specialized antibody products. The contract encompasses two distinct line items: 400 units of Anti-CD31 antibody [P2B1] and 455 units of Anti-Olig2 antibody [EPR2673], an oligodendrocyte marker. Both items are priced at one dollar per unit. The cumulative contract value is $856.
Epitomics Inc will deliver the antibody products directly to the University of Virginia buyer in Virginia. The Anti-CD31 and Anti-Olig2 antibodies represent research-grade reagents typically utilized in biomedical and life sciences applications, including immunohistochemistry and cell characterization studies. This procurement supports the University of Virginia's research and laboratory operations within the Commonwealth of Virginia.
Line items
| Item | Total |
|---|---|
| Anti-CD31 antibody [P2B1] | $400.00 |
| Anti-Olig2 antibody [EPR2673] - Oligodendrocyte Marker | $455.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0435441-V3?
Contract A207_PO-0435441-V3 was awarded to Epitomics Inc by University of Virginia on September 26, 2026.
How much is contract A207_PO-0435441-V3 worth?
Its cumulative value is $856.35.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award